• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冠状动脉内给药后依诺昔酮对血流动力学、心肌灌注及局部室壁运动的急性影响]

[Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion].

作者信息

Mitrovic V, Strasser R, Berwing K, Thormann J, Schlepper M

机构信息

Kerckhoff-Klinik, Bad Nauheim.

出版信息

Z Kardiol. 1996 Nov;85(11):856-67.

PMID:9064948
Abstract

The influence of intracoronary enoximone at a dose of 0.075 mg/ kg/10 min on global and regional wall motion and myocardial perfusion (Group I, n = 10) as well as on diastolic LV function (Group II, n = 8) during pacing-induced ischemia was investigated in 18 patients with significant LAD stenoses. The hemodynamic parameters were determined by left heart catheterization, the systolic and diastolic left ventricular function by echocardiography including Doppler technique, and myocardial perfusion analysis was done after intracoronary application of contrast medium. Enoximone did not change either heart rate (79 +/- 9 vs 80 +/- 9 min-1) or blood pressure (LVSP: 159 +/- 7 vs 162 +/- 5 mm Hg) at rest. In the postpacing ischemic period after enoximone, LVEDP fell from a mean of 28.9 to 18.4 mm Hg (p < 0.001), dp/dtmax increased from 1050 to 1369 mm Hg/s (p < 0.001) and regional EF from 47% to 58% (p < 0.01), while global EF remained unchanged (45% vs 47%). ST-segment depression was reduced significantly from 2.3 to 1.5 mm (p < 0.01). Enoximone induced an increase in myocardial perfusion by 129% (p < 0.001) in the stenosis-dependent myocardial areas with shortening of the wash-out half-life time of the echo contrast medium from a mean of 14 s to 5 s (p < 0.001). The isovolumetric relaxation was shortened by 13% (p < 0.05), the E wave by 5%, and dp/dtmin increased by 17% (p < 0.01). In summary, intracoronary application of enoximone led to an improvement in both systolic and diastolic LV function without concomitant peripheral effect due to regression of myocardial ischemia.

摘要

在18例患有严重左前降支狭窄的患者中,研究了剂量为0.075mg/kg/10min的冠状动脉内依诺昔酮在起搏诱导缺血期间对整体和局部室壁运动及心肌灌注(I组,n = 10)以及左心室舒张功能(II组,n = 8)的影响。通过左心导管检查测定血流动力学参数,采用包括多普勒技术的超声心动图测定左心室收缩和舒张功能,并在冠状动脉内注入造影剂后进行心肌灌注分析。依诺昔酮在静息时既不改变心率(79±9次/分钟 vs 80±9次/分钟)也不改变血压(左心室收缩压:159±7mmHg vs 162±5mmHg)。在依诺昔酮后的起搏后缺血期,左心室舒张末期压力从平均28.9mmHg降至18.4mmHg(p<0.001),dp/dtmax从1050mmHg/s增加至1369mmHg/s(p<0.001),局部射血分数从47%增加至58%(p<0.01),而整体射血分数保持不变(45% vs 47%)。ST段压低从2.3mm显著降低至1.5mm(p<0.01)。依诺昔酮使狭窄相关心肌区域的心肌灌注增加129%(p<0.001),同时回声造影剂的洗脱半衰期从平均14秒缩短至5秒(p<0.001)。等容舒张期缩短13%(p<0.05),E波缩短5%,dp/dtmin增加17%(p<0.01)。总之,冠状动脉内应用依诺昔酮可改善左心室收缩和舒张功能,且由于心肌缺血的消退而无伴随的外周效应。

相似文献

1
[Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion].[冠状动脉内给药后依诺昔酮对血流动力学、心肌灌注及局部室壁运动的急性影响]
Z Kardiol. 1996 Nov;85(11):856-67.
2
[Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].经冠状动脉内注射双嘧达莫在经皮腔内冠状动脉成形术(PTCA)期间的药理心肌保护作用:血流动力学、收缩功能及心室动态变化
Z Kardiol. 1995 Nov;84(11):898-910.
3
[The anti-ischemic effect of phosphodiesterase III inhibitors].[磷酸二酯酶III抑制剂的抗缺血作用]
Z Kardiol. 1994;83 Suppl 2:27-36.
4
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].依诺昔酮在重症监护病房急性和亚急性心力衰竭患者中的应用
Z Kardiol. 1994;83 Suppl 2:21-5.
5
Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.移植前患者的低剂量依诺昔酮治疗:血流动力学、超声心动图及神经体液学发现。
Z Kardiol. 1994;83 Suppl 2:49-53.
6
[Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
Z Kardiol. 1988 Oct;77(10):660-7.
7
Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.高剂量静脉注射地尔硫䓬对心室功能正常与受损患者的血流动力学耐受性及抗缺血疗效
J Am Coll Cardiol. 1993 Mar 1;21(3):709-20. doi: 10.1016/0735-1097(93)90104-9.
8
[Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].[依诺昔酮与多巴胺联合治疗中的神经体液和血流动力学效应]
Z Kardiol. 1994;83 Suppl 2:37-48.
9
Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis.先发性依诺昔酮对主动脉瓣狭窄瓣膜置换术后左心室舒张功能的影响。
J Cardiothorac Vasc Anesth. 2007 Jun;21(3):357-66. doi: 10.1053/j.jvca.2006.01.006. Epub 2006 May 4.
10
Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease.
Anesth Analg. 1994 Dec;79(6):1059-65. doi: 10.1213/00000539-199412000-00007.

引用本文的文献

1
Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist.心脏手术患者的左心室舒张功能障碍;心脏外科医生和心脏麻醉医生的观点
J Cardiothorac Surg. 2009 Nov 24;4:67. doi: 10.1186/1749-8090-4-67.